PCN9 VALIDITY OF PROPORTIONAL HAZARDS (PH) WEIBULL MODELS FOR ANALYZING PROGRESSION FREE SURVIVAL (PFS) AND OVERALL SURVIVAL (OS) IN PATIENTS WITH TRASTUZUMAB (TZ)-REFRACTORY ERBB2C) VERSUS CAPECITABINE ONLY (C-ONLY)
Abstract
Authors
O Sofrygin T Delea P Tappenden J Karnon MM Amonkar M Walker